BRPI0708095B8 - método para isolar uma fração bioativa, e, ingrediente bioativo - Google Patents

método para isolar uma fração bioativa, e, ingrediente bioativo

Info

Publication number
BRPI0708095B8
BRPI0708095B8 BRPI0708095A BRPI0708095A BRPI0708095B8 BR PI0708095 B8 BRPI0708095 B8 BR PI0708095B8 BR PI0708095 A BRPI0708095 A BR PI0708095A BR PI0708095 A BRPI0708095 A BR PI0708095A BR PI0708095 B8 BRPI0708095 B8 BR PI0708095B8
Authority
BR
Brazil
Prior art keywords
bioactive
present
fraction
gamma
relates
Prior art date
Application number
BRPI0708095A
Other languages
English (en)
Inventor
Koganov Michael
Original Assignee
Akzo Nobel Surface Chemistry Llc
Integrated Botanical Tech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38438098&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0708095(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Surface Chemistry Llc, Integrated Botanical Tech Llc filed Critical Akzo Nobel Surface Chemistry Llc
Publication of BRPI0708095A2 publication Critical patent/BRPI0708095A2/pt
Publication of BRPI0708095B1 publication Critical patent/BRPI0708095B1/pt
Publication of BRPI0708095B8 publication Critical patent/BRPI0708095B8/pt
Publication of BRPI0708095C1 publication Critical patent/BRPI0708095C1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)

Abstract

ingrediente bioativo, método para isolar uma fração bioativa, e, composição bioativa. a presente invenção refere-se a ingredientes bioativos que incluem frações bioativas isoladas derivadas de suco de células de biomassa fresca de uma planta de matricária (tanacetum parthenium). as frações bioativas são ou livres de ou substancialmente livres de (gama)-lactonas (alfa)-insaturadas (por exemplo, partenolídeo). além disso, as frações bioativas tem atividade antiinflamatória e antioxidante. a presente invenção também refere-se a um método para isolar uma fração bioativa que é derivada de suco de células de biomassa fresca de uma planta de matricária (tanacetum parthenium) e que é pelo menos substancialmente livre de (gama)-lactonas (alfa)-insaturadas (por exemplo partenolídeo). a presente invenção também refere- se a um método para preparar uma fração de soro de suco de células estabilizada e uma fração de soro de suco de células concentrada estabilizada que são livres de (gama)-lactonas (gama)-insaturadas (por exemplo, partenolídeo). a presente invenção também refere-se a uma composição bioativa que inclui uma mistura de uma ou mais das frações bioativas isoladas da presente invenção.
BRPI0708095A 2006-02-21 2007-02-21 método para isolar uma fração bioativa, e, ingrediente bioativo BRPI0708095C1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77525706P 2006-02-21 2006-02-21
US60/775257 2006-02-21
PCT/US2007/062498 WO2007098471A2 (en) 2006-02-21 2007-02-21 Parthenolide free bioactive ingredients from feverfew (tanacetum parthenium) and processes for their production

Publications (4)

Publication Number Publication Date
BRPI0708095A2 BRPI0708095A2 (pt) 2011-05-17
BRPI0708095B1 BRPI0708095B1 (pt) 2021-03-02
BRPI0708095B8 true BRPI0708095B8 (pt) 2021-03-23
BRPI0708095C1 BRPI0708095C1 (pt) 2021-05-25

Family

ID=38438098

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0708095A BRPI0708095C1 (pt) 2006-02-21 2007-02-21 método para isolar uma fração bioativa, e, ingrediente bioativo

Country Status (10)

Country Link
US (3) US7537791B2 (pt)
EP (1) EP1991242B1 (pt)
JP (4) JP5336859B2 (pt)
CN (1) CN101453898B (pt)
AU (1) AU2007217003B2 (pt)
BR (1) BRPI0708095C1 (pt)
CA (1) CA2643255A1 (pt)
ES (1) ES2625848T3 (pt)
NZ (2) NZ607880A (pt)
WO (1) WO2007098471A2 (pt)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8277852B2 (en) * 2002-01-25 2012-10-02 Akzo Nobel Surface Chemistry Llc Bioactive botanical cosmetic compositions and processes for their production
US8080265B2 (en) 2009-02-20 2011-12-20 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating signs of skin aging
US20110081430A1 (en) 2009-10-02 2011-04-07 Simarna Kaur COMPOSITIONS COMPRISING AN NFkB-INHIBITOR AND A TROPOELASTIN PROMOTER
IN2012DN02441A (pt) * 2009-10-02 2015-08-21 Johnson & Johnson Consumer
US8916209B2 (en) * 2009-10-02 2014-12-23 Johnson & Johnson Consumer Companies, Inc. Extracts of Phyllanthus niruri
US20110081305A1 (en) * 2009-10-02 2011-04-07 Steven Cochran Compositions comprising a skin-lightening resorcinol and a skin darkening agent
US8075931B2 (en) * 2009-10-02 2011-12-13 Johnson & Johnson Consumer Companies, Inc. Extracts of Phyllanthus niruri
US8084504B2 (en) * 2009-10-02 2011-12-27 Johnson & Johnson Consumer Companies, Inc. High-clarity aqueous concentrates of 4-hexylresorcinol
US8075930B2 (en) * 2009-10-02 2011-12-13 Johnson & Johnson Consumer Companies, Inc. Extracts of Phyllanthus niruri
US8906432B2 (en) 2009-10-02 2014-12-09 Johnson & Johnson Consumer Companies, Inc. Compositions comprising an NFκB-inhibitor and a non-retinoid collagen promoter
EP2499234B1 (en) * 2009-11-11 2016-10-05 ISP Investments Inc. Bioactive fractions from stress-induced photosynthetic organisms and methods of their manufacture and use
US9168207B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9161958B2 (en) 2010-08-19 2015-10-20 Johnson & Johnson Consumer Inc. Methods of treating cellulite
CA2808193A1 (en) 2010-08-19 2012-02-23 Johnson & Johnson Consumer Companies, Inc. Compositions comprising paulownin and/or paulownia extracts and uses thereof
US9962326B2 (en) 2010-08-19 2018-05-08 Johnson & Johnson Consumer Inc. Compositions comprising paulownia tomentosa wood extracts and uses thereof
US9173913B2 (en) 2010-08-19 2015-11-03 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9387349B2 (en) 2010-08-19 2016-07-12 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9168279B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising paulownin and/or Paulownia extracts and uses thereof
US9168219B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US8895628B2 (en) 2010-10-25 2014-11-25 Johnson & Johnson Consumer Companies, Inc. Compositions comprising a retinoid and an NFkB-inhibitor and their methods of use
US8293293B2 (en) 2010-12-17 2012-10-23 Johnson & Johnson Consumer Companies, Inc. Compositions comprising Lilium martagon extracts and uses thereof
US8481093B2 (en) * 2010-12-17 2013-07-09 Johnson & Johnson Consumer Companies, Inc. Compositions comprising Lilium candidum extracts and uses thereof
EP2465489B1 (en) 2010-12-17 2018-08-22 Johnson & Johnson Consumer Inc. Compositions comprising lilium martagon extracts and uses thereof
US9421236B2 (en) 2010-12-17 2016-08-23 Johnson & Johnson Consumer Inc. Compositions comprising Lilium siberia extracts and uses thereof
US8486466B2 (en) 2010-12-17 2013-07-16 Johnson & Johnson Consumer Companies, Inc. Compositions comprising Lilium siberia extracts and uses thereof
ES2573713T3 (es) 2010-12-17 2016-06-09 Johnson & Johnson Consumer Companies Inc. Composiciones que comprenden extractos de Lilium candidum y uso de las mismas
EP2465490A3 (en) 2010-12-17 2015-06-17 Johnson & Johnson Consumer Companies Inc. Compositions comprising Lilium Siberia extracts and uses thereof
US9492492B2 (en) 2010-12-17 2016-11-15 Johnson & Johnson Consumer Inc. Compositions comprising Lilium martagon extracts and uses thereof
WO2013092698A2 (en) 2011-12-22 2013-06-27 Akzo Nobel Chemicals International B.V. Bioactive compositions having hair anti aging activity
JP5860166B2 (ja) 2011-12-22 2016-02-16 ザ プロクター アンド ギャンブルカンパニー 皮膚の処置のための組成物及び方法
BR112014014692B1 (pt) 2011-12-22 2019-01-29 Akzo Nobel Chemicals International B.V. composição bioativa
MX352276B (es) 2011-12-22 2017-11-16 Procter & Gamble Composiciones y metodos para mejorar la apariencia del cabello envejecido.
US9814659B2 (en) 2012-04-02 2017-11-14 Johnson & Johnson Consumer Inc. Methods of lightening the skin
US20140086859A1 (en) 2012-09-24 2014-03-27 Johnson & Johnson Consumer Companies, Inc. Low oil compositions comprising a 4-substituted resorcinol and a high carbon chain ester
US20150258012A1 (en) 2012-11-14 2015-09-17 Akzo Nobel Chemicals International B.V. Method for preparing bioactive botanical compositions and the compositions made from said method
SG10201707422UA (en) * 2013-03-13 2017-10-30 Akzo Nobel Chemicals Int Bv Bioactive botanical compositions and uses thereof
US9579278B2 (en) 2013-05-10 2017-02-28 Johnson & Johnson Consumer Inc. Compositions comprising extracts of Bursera simaruba
MX2015015676A (es) 2013-05-16 2016-03-04 Procter & Gamble Composiciones de espesamiento para el cabello y metodos de uso.
EP2829303A1 (en) 2013-07-22 2015-01-28 Johnson & Johnson Consumer Companies Inc. Compositions comprising extract of malva neglecta and method of treating a skin condition with malva neglecta
US9522168B2 (en) 2014-05-29 2016-12-20 Johnson & Johnson Consumer Inc. Topical compositions comprising Acmella oleracea extracts and uses thereof
RU2601813C1 (ru) * 2015-04-22 2016-11-10 Ильзира Ильсуровна Гибадулина Способ мацерации тканей листа липы мелколистной tilia cordata mill
CN106691902B (zh) 2015-08-14 2021-04-20 强生消费者公司 包含显齿蛇葡萄和合欢提取物的组合物和使用方法
JP6833858B2 (ja) 2015-09-29 2021-02-24 ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドＪｏｈｎｓｏｎ ＆ Ｊｏｈｎｓｏｎ Ｃｏｎｓｕｍｅｒ Ｉｎｃ． シマレンガタケの細胞培養抽出物を使用した、皮膚を美白するための方法及び組成物
US20170128357A1 (en) 2015-11-06 2017-05-11 Johnson & Johnson Consumer Inc. Topical gel cream composition
US10335363B2 (en) 2015-12-08 2019-07-02 The Procter & Gamble Company Skin care composition and method of making the same
WO2017100109A1 (en) 2015-12-08 2017-06-15 The Procter & Gamble Company Method of regulating a condition of mammalian keratinous tissue
US10537515B2 (en) 2015-12-08 2020-01-21 The Procter & Gamble Company Personal care composition and method of making the same
US10182981B2 (en) 2015-12-08 2019-01-22 The Procter & Gamble Company Method of regulating a skin condition
US20170172913A1 (en) 2015-12-17 2017-06-22 Johnson & Johnson Consumer Inc. Topical Compositions Comprising Pichia Anomala and Chicory Root Extracts
CN105561321B (zh) * 2015-12-28 2019-04-12 陕西嘉禾生物科技股份有限公司 一种小白菊内酯的稳定方法
EP3419721B1 (en) 2016-02-25 2022-08-03 ISP Investments LLC Mitigating adverse effects of sunlight with ingredients obtained from living plants
CN105815326B (zh) * 2016-03-11 2020-10-16 江苏省中国科学院植物研究所 含小白菊内酯的农用杀菌剂制备方法及其用途
CN109689026B (zh) 2016-09-07 2022-08-30 Isp投资有限公司 使用包含生物活性莲提取物的组合物增加脂肪分解的方法
US10206870B2 (en) 2016-12-12 2019-02-19 Johnson & Johnson Consumer Inc. Topical composition containing glycerin and yeast extract
US10543240B2 (en) 2016-12-12 2020-01-28 Johnson & Johnson Consumer Inc. Topical composition containing glycerin and yeast extract
AU2019311846B2 (en) 2018-07-27 2023-02-23 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
AU2019311848B2 (en) 2018-07-27 2024-08-01 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US20200030226A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Consumer Inc. Botanical and bacterial extracts displaying retinol-like activity
US11166997B2 (en) 2018-07-27 2021-11-09 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
WO2020021481A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Vision Care, Inc. Compositions and methods for treating the eye
JP2021532121A (ja) 2018-07-27 2021-11-25 ジョンソン・アンド・ジョンソン・サージカル・ビジョン・インコーポレイテッド 眼を治療するための組成物及び方法
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11110051B2 (en) 2018-08-30 2021-09-07 Johnson & Johnson Consumer Inc. Topical compositions comprising Pichia anomala and n-acetyl glucosamine
AU2019203692B2 (en) 2018-08-30 2024-12-12 Kenvue Brands Llc Topical composition containing glycerin and yeast extract
US11045416B2 (en) 2018-08-30 2021-06-29 Johnson & Johnson Consumer Inc. Topical compositions comprising Pichia anomala and retinol
US20200069562A1 (en) 2018-08-30 2020-03-05 Johnson & Johnson Consumer Inc. Topical compositions comprising pichia anomala and a soy product
KR20210104760A (ko) 2018-12-18 2021-08-25 존슨 앤드 존슨 컨수머 인코포레이티드 개인맞춤형 국소 적용 패치
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
EP3824895A1 (en) 2019-11-19 2021-05-26 Johnson & Johnson Consumer Inc. Compositions and methods for treating the eye
US11969451B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US20210299203A1 (en) 2020-03-26 2021-09-30 Johnson & Johnson Consumer Inc. Compositions comprising carum carvi and rosmarinus officinalis extracts and methods of using same
EP4125979B1 (en) 2020-03-26 2026-03-11 Kenvue Brands LLC Compositions comprising carum carvi and rosmarinus officinalis extracts
EP4059508A1 (en) 2021-03-19 2022-09-21 Johnson & Johnson Consumer Inc. Methods of using compositions comprising an iceland moss extract
EP4170315A1 (en) 2021-10-22 2023-04-26 Johnson & Johnson Consumer Inc. Methods of evaluating micro rna
EP4252860A1 (en) 2022-03-31 2023-10-04 Johnson & Johnson Consumer Inc. Anhydrous formulations suitable as lip balms
CN115124496A (zh) * 2022-08-02 2022-09-30 中国标准化研究院 一种芙蓉菊类活性成分化合物及其制备方法
JP2024055621A (ja) * 2022-10-07 2024-04-18 株式会社コーセー 皮膚恒常性維持外用剤、これを含む化粧品、医薬品、及び医薬部外品、並びに、皮膚恒常性維持方法
EP4648739A1 (en) 2023-01-11 2025-11-19 Kenvue Brands LLC Compositions comprising compounds having retinol-like activity and a processed oat ingredient
JP2026503091A (ja) 2023-01-11 2026-01-27 ケンビュー・ブランズ・エルエルシー 敏感肌への使用に好適な組成物及びそれを使用する方法
WO2024150173A1 (en) 2023-01-11 2024-07-18 Johnson & Johnson Consumer Inc. Skincare formulations comprising phenyl propionic acid derivatives and methods using same
WO2024165954A1 (en) 2023-02-06 2024-08-15 Johnson & Johnson Consumer Inc. Cutibacterium acnes biomimetic, prebiotic, probiotic and postbiotic compositions for treatment of skin conditions
WO2026003722A1 (en) 2024-06-24 2026-01-02 Kenvue Brands Llc Compositions comprising compounds having retinol-like activity and an n-acetyl compound
WO2026003725A1 (en) 2024-06-24 2026-01-02 Kenvue Brands Llc Compositions comprising compounds having retinol-like activity and a polyhydroxy acid

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030003170A1 (en) 2000-06-02 2003-01-02 Theresa Callaghan Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
ES2239010T3 (es) * 1999-06-03 2005-09-16 JOHNSON & JOHNSON CONSUMER FRANCE SAS Extractos de chrysanthemum matricaire (tanacetum parthenium) utilizados contra los trastornos inflamatorios.
IT1312342B1 (it) * 1999-06-03 2002-04-15 Indena Spa Estratto di tanacetum parthenium sostanzialmente privo di gammalattoni-alfa-insaturi.
GB9913408D0 (en) 1999-06-10 1999-08-11 Albright & Wilson Uk Ltd Personal care formulations
US7074747B1 (en) 1999-07-01 2006-07-11 Johnson & Johnson Consumer Companies, Inc. Cleansing compositions
AU5764800A (en) 1999-07-01 2001-01-22 Johnson & Johnson Consumer Companies, Inc. Cleansing compositions
US6762158B2 (en) 1999-07-01 2004-07-13 Johnson & Johnson Consumer Companies, Inc. Personal care compositions comprising liquid ester mixtures
US20050009717A1 (en) 1999-07-01 2005-01-13 Lukenbach Elvin R. Foaming make-up removing cleansing compositions
US6908630B2 (en) * 2000-08-01 2005-06-21 Metaproteomics, Llc Combinations of sesquiterpene lactones and ditepene triepoxide lactones for synergistic inhibition of cyclooxygenase-2
CN100539984C (zh) 2001-03-16 2009-09-16 强生消费者公司 含有小白菊提取物的组合物及其用途
US20030077343A1 (en) 2001-03-16 2003-04-24 Martin Katharine M. Composition containing feverfew extract and use thereof
US7442391B2 (en) * 2002-01-25 2008-10-28 Integrated Botanical Technologies, Llc Bioactive botanical cosmetic compositions and processes for their production
US20050148910A1 (en) 2003-12-24 2005-07-07 Gregory Skover Apparatus having a skin-contactable element containing an agent
PL1722805T3 (pl) * 2004-01-12 2014-08-29 Akzo Nobel Surface Chemistry Llc Biologicznie czynne kompozycje z roślin Theacea oraz sposoby ich wytwarzania i zastosowanie
US20070086972A1 (en) 2005-09-12 2007-04-19 Jacob Birnbaum Hair growth compositions and methods for treating hair loss or related conditions
US8617857B2 (en) * 2010-05-04 2013-12-31 Korea Research Institute Of Bioscience And Biotechnology Thraustochytrid-based microalgae, and method for preparing bio-oil by using same

Also Published As

Publication number Publication date
BRPI0708095A2 (pt) 2011-05-17
JP5336859B2 (ja) 2013-11-06
BRPI0708095C1 (pt) 2021-05-25
CN101453898B (zh) 2014-03-26
USRE46788E1 (en) 2018-04-17
BRPI0708095B1 (pt) 2021-03-02
JP2009527582A (ja) 2009-07-30
EP1991242B1 (en) 2017-04-26
AU2007217003B2 (en) 2013-04-04
JP6141912B2 (ja) 2017-06-07
EP1991242A4 (en) 2010-11-03
EP1991242A2 (en) 2008-11-19
ES2625848T3 (es) 2017-07-20
WO2007098471A2 (en) 2007-08-30
NZ595600A (en) 2013-03-28
US20090186109A1 (en) 2009-07-23
US8728548B2 (en) 2014-05-20
WO2007098471A3 (en) 2008-11-20
JP2013151544A (ja) 2013-08-08
US20070196523A1 (en) 2007-08-23
US7537791B2 (en) 2009-05-26
CN101453898A (zh) 2009-06-10
JP2017061476A (ja) 2017-03-30
AU2007217003A1 (en) 2007-08-30
NZ607880A (en) 2014-11-28
JP2015205906A (ja) 2015-11-19
CA2643255A1 (en) 2007-08-30

Similar Documents

Publication Publication Date Title
BRPI0708095C1 (pt) método para isolar uma fração bioativa, e, ingrediente bioativo
Odiatou et al. Identification of the factors responsible for the in vitro pro-oxidant and cytotoxic activities of the olive polyphenols oleuropein and hydroxytyrosol
BR112022002953A2 (pt) Composições e métodos para condicionamento não tóxico
EP4360651A3 (en) Glp-1 compositions and uses thereof
ECSP077316A (es) Compuestos imidazo-3-il-amina bicíclicos sustituidos
BR112012028290A2 (pt) desintoxicação de acetato derivado de biomassa via conversão metabólica em etanol, acetona, isopropanol ou acetato de etila
BR112013003755A2 (pt) composições de goma que umedecem a boca e produtos que contêm as mesmas
BR112017025339A2 (pt) composições nutricionais contendo um nível elevado de inositol e usos das mesmas
AR003496A1 (es) Procedimiento de tratamiento cosmetico no terapeutico de desordenes asociados con un exceso de sintesis y/o liberacion del cgrp y/o de sustancia p utilizacion de al menos un extracto de celulas de la menos un vegetal de la familia de las iridaceas y composicion cosmetica o farmaceutica que comprende dicho extracto
BRPI0801858A2 (pt) uso de pelo menos um meio de cultura celular condicionado ou de seu extrato e composiÇço cosmÉtica ou dermatolàgica
BR112012028711A2 (pt) métodos para a fabricação de uma emulsão de óleo em água, para a preparação de um kit de vacina e para redestilação de uma composição compreendendo 99% de esqualeno ou mais, assim como emulsão de óleo em água e kit
Roubalová et al. Flavonolignan 2, 3-dehydrosilydianin activates Nrf2 and upregulates NAD (P) H: quinone oxidoreductase 1 in Hepa1c1c7 cells
BR112021021557A2 (pt) Corpos de cetona confinados em microesferas
BRPI0916936B8 (pt) composições farmacêuticas, uso de clevidipina e método de reduzir impurezas.
BR112019024641A2 (pt) Composições de óleo contendo éster alquílico intensificado e métodos de fabricação e utilização das mesmas
BR112018016307A2 (pt) usos de composição e de produto, método de combate a maus odores e composição
BR112022014714A2 (pt) Composição de gordura adequada como um equivalente a manteiga de cacau tendo uma baixa quantidade de diglicerídeos
BR112022025449A2 (pt) Composição imunológica útil para induzir a produção de anticorpos para um antígeno em um animal não humano, e, uso da mesma
BR112015020365A2 (pt) fração bioativa derivada de fruta, composição, e método para isolar uma fração bioativa
BR112019011812A2 (pt) composições nutricionais contendo butirato e usos das mesmas
PE20211483A1 (es) Composiciones de acidos grasos poliinsaturados enriquecidos con ala
TR201818784T4 (tr) Selenyum İle Kombinasyon Halinde Aronia Sp.'nin Bir Ekstraktını İçeren Bağışık Uyarıcı Terkip
JOP20220136A1 (ar) صياغات تشتمل على معدن و/أو فيتامين وبولي سكاريد، تركيبات منها واستخدامها في المعدن و/أو الفيتامين المُكمل المذكور
MX2020010425A (es) Composicion isotopicamente modificada y sus usos terapeuticos.
BR112014027301A2 (pt) composição que compreende um ingrediente sensível

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25A Requested transfer of rights approved

Owner name: AKZO NOBEL SURFACE CHEMISTRY LLC (US)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/03/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2617 DE 02/03/2021 QUANTO AO QUADRO REIVINDICATORIO.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/02/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B15V Prolongation of time limit allowed